171,010 Shares in Nova Ltd. $NVMI Purchased by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Nova Ltd. (NASDAQ:NVMI) during the fourth quarter, HoldingsChannel reports. The firm bought 171,010 shares of the semiconductor company’s stock, valued at approximately $56,158,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC boosted its holdings in Nova by 9.4% during the fourth quarter. EverSource Wealth Advisors LLC now owns 280 shares of the semiconductor company’s stock valued at $92,000 after purchasing an additional 24 shares in the last quarter. Signaturefd LLC boosted its holdings in Nova by 4.5% during the fourth quarter. Signaturefd LLC now owns 992 shares of the semiconductor company’s stock valued at $326,000 after purchasing an additional 43 shares in the last quarter. Farther Finance Advisors LLC boosted its holdings in Nova by 16.1% during the fourth quarter. Farther Finance Advisors LLC now owns 347 shares of the semiconductor company’s stock valued at $114,000 after purchasing an additional 48 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in Nova by 0.5% during the fourth quarter. The Manufacturers Life Insurance Company now owns 10,885 shares of the semiconductor company’s stock valued at $3,642,000 after purchasing an additional 53 shares in the last quarter. Finally, CIBC Private Wealth Group LLC boosted its holdings in Nova by 75.7% during the third quarter. CIBC Private Wealth Group LLC now owns 130 shares of the semiconductor company’s stock valued at $42,000 after purchasing an additional 56 shares in the last quarter. 82.99% of the stock is owned by institutional investors and hedge funds.

Nova Price Performance

Shares of NVMI opened at $583.05 on Monday. The company has a market capitalization of $18.53 billion, a P/E ratio of 72.70, a PEG ratio of 4.23 and a beta of 1.75. Nova Ltd. has a one year low of $217.50 and a one year high of $588.40. The business’s 50 day simple moving average is $507.47 and its 200-day simple moving average is $441.02.

Nova (NASDAQ:NVMI) last announced its earnings results on Thursday, May 14th. The semiconductor company reported $2.33 EPS for the quarter, topping the consensus estimate of $2.20 by $0.13. The business had revenue of $235.31 million for the quarter, compared to the consensus estimate of $227.02 million. Nova had a return on equity of 21.77% and a net margin of 29.21%.Nova’s revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the business earned $2.18 EPS. Nova has set its Q2 2026 guidance at 2.340-2.480 EPS. On average, sell-side analysts anticipate that Nova Ltd. will post 9.44 EPS for the current fiscal year.

Insider Transactions at Nova

In related news, Director Eitan Oppenhaim sold 1,504 shares of the business’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $519.48, for a total value of $781,297.92. Following the completion of the transaction, the director owned 6,668 shares in the company, valued at $3,463,892.64. The trade was a 18.40% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Yaniv Garty sold 426 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $514.49, for a total transaction of $219,172.74. Following the completion of the transaction, the director owned 2,038 shares of the company’s stock, valued at $1,048,530.62. This trade represents a 17.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,411 shares of company stock valued at $1,243,018 in the last three months. 1.00% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on NVMI shares. Needham & Company LLC lifted their price objective on Nova from $500.00 to $640.00 and gave the company a “buy” rating in a report on Thursday, May 14th. Weiss Ratings raised Nova from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 14th. Evercore reaffirmed an “outperform” rating and set a $600.00 price objective on shares of Nova in a report on Friday, May 15th. Jefferies Financial Group lifted their price objective on Nova from $520.00 to $640.00 and gave the company a “buy” rating in a report on Thursday, May 14th. Finally, Citigroup boosted their target price on Nova from $520.00 to $595.00 and gave the stock a “buy” rating in a report on Friday, May 15th. Nine investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $518.22.

Nova Profile

Nova Measuring Instruments Ltd (NASDAQ: NVMI) develops and supplies advanced metrology and process control systems for the semiconductor manufacturing industry. The company’s core product line includes spectroscopic ellipsometry and scatterometry tools designed to measure film thickness, critical dimensions, overlay alignment and other key parameters that drive yield and performance in integrated circuit fabrication.

Founded in 1993 and headquartered in Rehovot, Israel, Nova Measuring Instruments has established itself as a critical partner to leading semiconductor foundries and device manufacturers.